Pandion, Astellas collaborate for pancreas targeted immunomodulators

Japan |  News | 0 Comment | 31 Oct, 2019

US headquartered Pandion Therapeutics, Inc., and Japan based Astellas Pharma Inc. have announced the signing of a License and Collaboration Agreement directed toward the research, developme...Read more

Lobsor Pharma receives Japanese patent for APD solution

Japan |  News | 2 Comment | 01 Nov, 2019

Lobsor Pharmaceuticals AB, a privately held Swedish company based in Uppsala, has announced the Japanese Patent Office has issued a Decision to Grant a patent covering Lecigon® a new th...Read more

Hitachi takes advanced Proton Therapy to the US

Japan |  News | 0 Comment | 31 Oct, 2019

Japan headquartered Hitachi, Ltd., has announced that it has provided its advanced proton therapy system to Sibley Memorial Hospital (Washington DC, US), a member of Johns Hopkins Medicine ...Read more

Biogen plans regulatory filing for Aducanumab for Alzheimer's

Japan |  News | 0 Comment | 23 Oct, 2019

Biogen and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administration (FDA), Biogen plans to pursue regulatory approval for aducanumab, ...Read more

MIMS and Ashfield Communications combine operations in Japan

Japan |  News | 0 Comment | 24 Oct, 2019

MIMS Group, Asia's largest multi-channel provider of drug information, medical communications, events management and marketing services, and Ashfield Healthcare Communications KK, on 23&nbs...Read more

Rentschler Biopharma to expand Japanese operation base

Japan |  News | 0 Comment | 23 Oct, 2019

Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals, hasreported that it will further enhance and develop ...Read more

Takeda acquires license for celiac disease therapy

Japan |  News | 0 Comment | 22 Oct, 2019

Japanese firm Takeda Pharmaceutical Company  and US based COUR Pharmaceutical Development Company, Inc. have announced that Takeda has acquired an exclusive global license to develop a...Read more

Trastuzumab deruxtecan gets FDA priority review to treat metastatic breast cancer

Japan |  News | 0 Comment | 18 Oct, 2019

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) have announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA...Read more

Avidity Science acquires Edstrom Japan Ltd

Japan |  News | 0 Comment | 17 Oct, 2019

Avidity Science is pleased to announce it has completed its acquisition of Edstrom Japan Ltd. The acquisition furthers Avidity Science's efforts to build its global footprint supporting the...Read more

Dr. Steven Rosenberg's achievements in cancer immunotherapy motivate young researchers

Japan |  News | 0 Comment | 17 Oct, 2019

Using the function of the individual's own immune system to combat cancer, this out-of-the-box concept was proposed by Dr. Steven Rosenberg about thirty years ago. His initiative laid ...Read more

Astellas transfers three products in Asia region to Daiichi Sankyo

Japan |  News | 0 Comment | 17 Oct, 2019

Astellas Pharma Inc. has announced that subsidiaries of Astellas will transfer their marketing authorizations, trademark, and related contracts for “Nasea (5HT3 receptor antagoni...Read more

Takeda divests select OTC to Acino for over $200M

Japan |  News | 0 Comment | 16 Oct, 2019

Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a ...Read more

Canon Medical launches new division in Dubai, UAE

Japan |  News | 0 Comment | 14 Oct, 2019

Canon Medical Systems Corporation has announced the official opening of its Middle East Division in Canon Middle East Dubai, UAE. Preparations are now underway to start business operations ...Read more

Shionogi to develop treatment for mycobacterial diseases

Japan |  News | 0 Comment | 15 Oct, 2019

Japanese major research-driven pharmaceutical company Shionogi & Co., Ltd. has announced that it has entered into a new license agreement with US headquartered Hsiri Therapeut...Read more

Japanese firm advances diagnostic application of radiolabeling platform

Japan |  News | 0 Comment | 14 Oct, 2019

Fuzionaire Diagnostics, in partnership with Tokyo-based radiopharmaceutical company Japan Medical Isotope Technology Development K.K. (JAMIT), has announced the launch of Fuzionaire Radiois...Read more

Japan issues GMP Certificate to Lupin’s Mandideep facility

Japan |  News | 0 Comment | 11 Oct, 2019

Pharma major Lupin has announced the receipt of GMP (Good Manufacturing Practice) Certificate from the Pharmaceutical and Medical Devices Agency (PMDA), Japan for its Mandideep API facility...Read more

Viela Bio to develop autoimmune drug for nine Asian regions

Japan |  News | 0 Comment | 11 Oct, 2019

US based Viela Bio, Inc. and Japanese firm Mitsubishi Tanabe Pharma Corporation have announced a collaboration focused on the development and commercialization of inebilizumab – Viela...Read more

Daiichi Sankyo launches new drug for AML treatment

Japan |  News | 0 Comment | 11 Oct, 2019

Daiichi Sankyo Company, Limited has announced the launch of VANFLYTA® (quizartinib), an oral FLT3 inhibitor, in Japan for the treatment of adult patients with relapsed/refractory F...Read more